Evidence map›Paper›PMID 34899577›Full record

ArticleFrontiers in neurology2021

A National Representative, Cross-Sectional Study by the Hellenic Academy of NeuroImmunology (HEL.A.NI.) on COVID-19 and Multiple Sclerosis: Overall Impact and Willingness Toward Vaccination.

Marina Boziki, Charis Styliadis, Christos Bakirtzis, Eleni Grigoriadou, Aggeliki-Styliani Sintila, Ioannis Nikolaidis, Aliki Vrienniou, Lotte Geys, Sygkliti-Henrietta Pelidou, Lesley Probert and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Marina Boziki2nd Neurological University Department, Aristotle University of Thessaloniki, American Hellenic Educational and Progressive Association (AHEPA) General Hospital, Thessaloniki, Greece.
Charis StyliadisLaboratory of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Christos Bakirtzis2nd Neurological University Department, Aristotle University of Thessaloniki, American Hellenic Educational and Progressive Association (AHEPA) General Hospital, Thessaloniki, Greece.
Eleni Grigoriadou2nd Neurological University Department, Aristotle University of Thessaloniki, American Hellenic Educational and Progressive Association (AHEPA) General Hospital, Thessaloniki, Greece.
Aggeliki-Styliani Sintila2nd Neurological University Department, Aristotle University of Thessaloniki, American Hellenic Educational and Progressive Association (AHEPA) General Hospital, Thessaloniki, Greece.
Ioannis Nikolaidis2nd Neurological University Department, Aristotle University of Thessaloniki, American Hellenic Educational and Progressive Association (AHEPA) General Hospital, Thessaloniki, Greece.
Aliki VrienniouHellenic Federation of Persons With Multiple Sclerosis, Athens, Greece.
Lotte GeysUniversity MS Center (UMSC), Campus Diepenbeek, Diepenbeek, Belgium.
Sygkliti-Henrietta PelidouHellenic Academy of NeuroImmunology (HEL.A.NI.), Thessaloniki, Greece.
Lesley ProbertHellenic Academy of NeuroImmunology (HEL.A.NI.), Thessaloniki, Greece.
Georgios PapazisisDepartment of Clinical Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Panagiotis BamidisLaboratory of Medical Physics and Digital Innovation, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Nikolaos Grigoriadis2nd Neurological University Department, Aristotle University of Thessaloniki, American Hellenic Educational and Progressive Association (AHEPA) General Hospital, Thessaloniki, Greece.
Aristotle University of Thessaloniki · GRAHEPA University Hospital · GRNational MS Center MelsbroekPasteur Hellenic Institute · GRUniversity of Ioannina · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

caregiversCOVID-19 pandemicinformation and communications technology (ICT) toolspeople with multiple sclerosis (PwMS)quality of life (QoL)vaccination

Identifiers

PMID34899577
PMCPMC8656423
OpenAlexW3216131990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.